Volume 42, Issue 5 pp. 799-802
Brief Communication
Full Access

Clinical and magnetic resonance imaging findings in batten disease: Analysis of the major mutation (1.02-kb deletion)

Dr. Irma Järvelä MD, PhD

Corresponding Author

Dr. Irma Järvelä MD, PhD

Laboratory of Human Molecular Genetics, National Public Health Institute, University of Helsinki, Helsinki, Finland

Laboratory of Human Molecular Genetics, Mannerheimintie 166, 00300 Helsinki, FinlandSearch for more papers by this author
Taina Autti MD

Taina Autti MD

Department of Paediatric Neurology, Children's Hospital, University of Helsinki, Finland

Department of Radiology, University of Helsinki, Helsinki, Finland

Search for more papers by this author
Sirkka Lamminranta MSc

Sirkka Lamminranta MSc

Department of Paediatric Neurology, Children's Hospital, University of Helsinki, Finland

Search for more papers by this author
Laura Åberg MD

Laura Åberg MD

Department of Paediatric Neurology, Children's Hospital, University of Helsinki, Finland

Search for more papers by this author
Raili Raininko MD

Raili Raininko MD

Department of Diagnostic Radiology, University of Uppsala, Uppsala, Sweden

Search for more papers by this author
Pirkko Santavuori MD

Pirkko Santavuori MD

Department of Paediatric Neurology, Children's Hospital, University of Helsinki, Finland

Search for more papers by this author
First published: 08 October 2004
Citations: 66

Abstract

A total of 36 patients with Batten disease (juvenile-onset neuronal ceroid lipofuscinosis), homozygous or heterozygous for the major mutation, a 1.02-kb deletion, in the CLN3 gene, were studied to relate their genotype to their clinical phenotype. The onset of visual failure and epilepsy was highly concordant in both groups. Great inter and intrafamilial heterogeneity was demonstrated in the development of mental and physical handicap and in magnetic resonance imaging findings among both homozygous and heterozygous patients. The 1.02-kb deletion in homozygous form was always associated with mental and physical handicap, whereas the heterozygous phenotype could be extremely benign without affecting the intellectual level of the patient. Our data suggest that genetic background, modifying genes, and environmental factors all influence the final phenotype of Batten disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me